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The differentiation capability of induced pluripotent
stem cells (iPSCs) toward certain cell types for dis-
ease modeling and drug screening assays might be
influenced by their somatic cell of origin. Here, we
have compared the neural induction of human iPSCs
generated from fetal neural stem cells (fNSCs),
dermal fibroblasts, or cord blood CD34+ hematopoi-
etic progenitor cells. Neural progenitor cells (NPCs)
and neurons could be generated at similar effi-
ciencies from all iPSCs. Transcriptomics analysis of
the whole genome and of neural genes revealed a
separation of neuroectoderm-derived iPSC-NPCs
from mesoderm-derived iPSC-NPCs. Furthermore,
we found genes that were similarly expressed in
fNSCs and neuroectoderm, but not in mesoderm-
derived iPSC-NPCs. Notably, these neural signatures
were retained after transplantation into the cortex
of mice and paralleled with increased survival of neu-
roectoderm-derived cells in vivo. These results indi-
cate distinct origin-dependent neural cell identities
indifferentiatedhuman iPSCsboth in vitro and in vivo.
INTRODUCTION
Induced pluripotent stem cells (iPSCs) carry distinct epigenetic
signatures, which, at least in part, are characteristic of theirCell Resomatic cell of origin (Kim et al., 2010, 2011; Lister et al., 2011;
Polo et al., 2010). Low-passage human iPSCs generated from
either hematopoietic cells or keratinocytes have a differentiation
bias toward their respective starting populations (Kim et al.,
2011). These signatures could influence sensitivities of in vitro
assays and may require thorough selection of appropriate start-
ing cells prior to iPSC generation. iPSC technology is especially
attractive for biomedical research on neurological diseases, as
neural cells are not easily accessible from the human brain (Har-
gus et al., 2014; Reinhardt et al., 2013b; Soldner et al., 2009).
However, it is currently not known to what extent neural induc-
tion is influenced by the cellular origin of human iPSCs and if
any origin-dependent neural cell identities exist, which could in-
fluence integrity and maturation of iPSC-derived neural cells
in vitro and in vivo.
RESULTS AND DISCUSSION
Robust Differentiation of Human iPSCs into Neural
Progenitor Cells In Vitro
To address these questions, we have generated human iPSCs
from either brain-derived fetal neural stem cells (fNSC-iPSCs),
from mesoderm-derived cord blood CD34+ hematopoietic
stem cells (HSCs; CD34+-iPSCs), or from dermal fibroblasts
(Fib-iPSCs). All iPSC lines were differentiated into neural progen-
itor cells (NPCs) according to a protocol we have recently devel-
oped (Reinhardt et al., 2013a). These NPCs expressed the neural
marker proteins NESTIN, SOX1, SOX2, and FOXA2 and were
morphologically indistinguishable between groups (Figure 1A).
Quantification revealed comparable differentiation capabilitiesports 8, 1697–1703, September 25, 2014 ª2014 The Authors 1697
Figure 1. Origin-Dependent Cell Identities in iPSC-Derived Neural Progenitor Cells
Human iPSCs from fetal neural stem cells (fNSCs), CD34+ hematopoietic stem cells (CD34+), and dermal fibroblasts (Fib) were differentiated into neural progenitor
cells (NPCs) along with human ESCs.
(A) Immunostainings of NPCs for neural progenitor marker molecules.
(B) Quantification of immunostainings for Nestin.
(C and D) Whole-genome expression profiles of starting cells (fNSCs, CD34, Fib), of undifferentiated iPSCs and ESCs, and of NPCs differentiated from
neuroectoderm- and mesoderm-derived iPSCs and from ESCs presented (C) as a heatmap and (D) as hierarchical clusters.
(E) Hierarchical cluster analysis of brain-associated neural genes.
(legend continued on next page)
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with about 90% NESTIN+ cells among the different NPC popu-
lations (fNSC-iPSC-NPC: 89.1% ± 7.2%; CD34-iPSC-NPC:
89.9% ± 3.9%; Fib-iPSC-NPC: 89.3% ± 4.6%; Figure 1B). This
high differentiation efficiency among all groups and the high
purity of cultures allowed us to perform whole-genome expres-
sion analysis on iPSC-derived neural cells. Thus, expression
profiles were collected from several fNSC-iPSC-NPC, CD34-
iPSC-NPC, and Fib-iPSC-NPC clones that had been differenti-
ated in parallel and in independent experiments. In addition,
we collected expression profiles of the starting cell populations
(fNSCs, CD34+ HSCs, and fibroblasts) and of undifferentiated
fNSC-iPSCs, CD34-iPSCs, and Fib-iPSCs (Figures 1C and
1D). As reference controls, undifferentiated human embryonic
stem cells (ESCs; lines H1 and HUES6) and differentiated
ESCs (H1-NPCs and HUES6-NPCs) were also included in the
analysis. As expected, the transcriptome analysis demonstrated
a clear separation of all NPCs from the starting cells as well as
from undifferentiated iPSCs and ESCs (Figures 1C and 1D).
Interestingly, among the NPC clones, we discovered that
neuroectoderm-derived fNSC-iPSC-NPCs clustered together
and separated from mesoderm-derived CD34-iPSC-NPCs and
Fib-iPSC-NPCs and from ESC-derived NPCs (Figure 1D). This
finding indicated that fNSC-iPSC-NPCs comprised a distinct
group among the NPCs, while CD34-iPSC-NPCs and Fib-
iPSC-NPCs did not separate as groups from each other in the
hierarchical cluster analysis. We would like to note that our
iPSCs had been generated with one, two, or four transcription
factors, which could have potentially led to differences in gene
expression profiles in iPSC-NPCs. However, whole-genome
expression analysis revealed reprogramming factor-indepen-
dent cluster formation of undifferentiated iPSCs with undifferen-
tiated ESCs and separation of lines within the NPC cluster,
which was independent of the number of reprogramming fac-
tors used for iPSC derivation. We then decided to further char-
acterize neural cell identities of iPSC-derived NPCs in vitro and
in vivo.
Identification of Origin-Dependent Cell Identities in
Human iPSC-Derived Neural Progenitor Cells In Vitro
The expression of common neural genes such as NESTIN,
PTPRZ1, POU3F2, SOX8, SOX2, HES5, and TUBB3 in NPCs
was similar among all NPC groups, demonstrating successful
generation of NPCs (Figure S1A). When performing an unbiased
expression analysis of 204 brain-associated neural genes ob-
tained from the TiGER database (Liu et al., 2008), we could
observe a separation of fNSC-iPSC-NPCs from all other NPCs,
as similarly seen in the whole-genome expression analysis
(Figure 1E; Figure S1B). Furthermore, we found that all NPC
groups clustered closest to fetal brain-derived fNSCs, while
undifferentiated iPSCs, CD34+ HSCs, and fibroblasts formed a
separate cluster.(F) Number and expression of signature genes similarly expressed in fNSCs and n
of differentially regulated genes (DEGs) in fNSCs and NPCs using a fold-change
(G) Validation of differential expression of signature genes.
(H) Immunostainings of differentiated NPCs for bIII-tubulin, TH, and GFAP.
(I) Quantification of immunostainings for bIII-tubulin, TH, and GFAP and of neurit
Data are presented as mean + SEM. One-way ANOVA with post hoc Tukey test
Cell ReThese findings provided additional clues to distinct neural
characteristics of fNSC-iPSC-NPCs and led us to analyze if
fNSC-iPSC-NPCs differed from CD34-iPSC-NPCs and Fib-
iPSC-NPCs in regard to their regional identity along the rostro-
caudal axis. Indeed, fNSC-iPSC-NPC, in contrast to the
mesoderm-derived NPCs, were derived from telencephalic pre-
cursor cells, which give rise to cortical and striatal tissue of the
developing brain (Kim et al., 2006). Thus, we wondered whether
positional identities were erased after derivation and in vitro
differentiation of iPSCs. To address this question, we had pur-
posely applied a differentiation protocol to our iPSCs that effi-
ciently generates midbrain/hindbrain precursor cells relevant
for disease modeling and drug screening assays in neurodegen-
erative diseases (Reinhardt et al., 2013a). We determined the
expression of FOXG1, LHX2, EMX2, DLX1, DLX2, OTX2, EN1,
EN2, FOXA2, HOXA2, and HOXD3 in fNSC-iPSC-NPCs in com-
parison to CD34-iPSC-NPCs and Fib-iPSC-NPCs (Figure S1C).
As expected, fNSCs showed strong expression of the rostral
genes FOXG1, LHX2, EMX2, and DLX1, while the midbrain-
associated genes EN1, EN2, and FOXA2 and the hindbrain-
associated marker HOXA2 were virtually not expressed. In
contrast, both neuroectoderm- and mesoderm-derived NPCs
expressed EN1, EN2, and FOXA2 and HOXA2, but not FOXG1,
LHX2, and EMX2, at high levels, validating the intended differen-
tiation of cells toward caudal domains. However, in contrast to
CD34-iPSC-NPCs and Fib-iPSC-NPCs, neuroectoderm-derived
fNSC-iPSC-NPCs still showed increased expression of the
telencephalic marker DLX1, indicating that origin-specific posi-
tional identities were vastly, but not entirely, erased in fNSC-
iPSC-NPCs (Figures S1C and S1D).
To further characterize neural identities in iPSC-derived NPCs,
we performed an unbiased analysis of genes, which were ex-
pressed at similar levels in fNSCs and fNSC-iPSC-NPCs but
differently expressed in mesodermal NPCs (Figures 1F and 1G;
Figure S2D). Since our study included both female and male
iPSCs and since an erosion of X chromosome inactivation and
thus an erosion of dosage compensation with altered expression
of X-linked genes has been described in high-passage iPSCs
from female donors (Mekhoubad et al., 2012), which could
potentially influence the discovery of origin-dependent signature
genes, we decided to exclude any sex chromosome-related
genes from this analysis by using only autosomal genes. This
approach revealed 20 genes, most of which (18 genes) are ex-
pressed in neural tissue, and for half of them (ACSF3, APLNR,
CART1, C7orf16, NXPH1, MAL, OCIAD2, SLC8A2, SLITRK1,
and TRNP1), neural functions such as neural cell adhesion, neu-
ral cell migration, or neurite outgrowth have been described
(Table S1). Notably, NXPH1, ACSF3, and TRNP1 were among
the most highly expressed genes in fNSCs and fNSC-iPSC-
NPCs, which are expressed in the developing and mature
cortex as derivative of the dorsal telencephalon. While NXPH1euroectoderm- or mesoderm-derived NPCs, calculated as specific intersection
threshold of the absolute value of the replicate mean differences of 4.
e formation.
was used as statistical test (*p < 0.05; ***p < 0.001).
ports 8, 1697–1703, September 25, 2014 ª2014 The Authors 1699
Figure 2. Origin-Dependent Neural Cell Identities in Differentiated iPSCs Are Conserved after Transplantation into the Rodent Brain
(A) Neuroectoderm-derived fNSC-iPSC-NPCs and mesoderm-derived Fib-iPSC-NPCs were transduced with lentiviruses expressing either GFP or dtTomato
RFP and cells were mixed at 1:1 ratio prior to transplantation.
(B–D) Nontransplanted NPCs were replated and analysis 1 day after transplantation revealed (B) equal survival rates and similar percentages of (C) proliferating
and of (D) apoptotic cells.
(E–K) fNSC-iPSC-NPCs and Fib-iPSC-NPCs were transplanted as mixed cultures into the cortex and striatum of adult mice (n = 4 for each site). (F) Quantification
of surviving cells and (G and H) of NeuN+ neurons within grafts 10 weeks after transplantation. (I–K) Immunostainings of cortical and striatal grafts for NeuN
demonstrating neuronal maturation of GFP+ and dtTomato+ cells.
(legend continued on next page)
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promotes adhesion between dendrites and axons via alpha neu-
rexins in the adult brain (Petrenko et al., 1996), alterations in
ACSF3 have been linked to mental retardation and the develop-
ment of seizures (Sloan et al., 2011). Interestingly, TRNP1 has
recently been discovered as a DNA-binding protein with essen-
tial modulating functions during tangential and radial migration of
neuroblasts within the developing cerebral cortex (Stahl et al.,
2013), corroborating the identification of distinct origin-depen-
dent identities in fNSC-iPSC-NPCs. Other genes were equally
downregulated in fNSCs and fNSC-iPSC-NPCs and included
OCIAD2, a g-secretase-activating gene highly expressed in pa-
tients with Alzheimer’s disease (Han et al., 2014), and CD70, a
nonneural surface molecule on T and B lymphocytes (Borst
et al., 2005). In line with the observation of origin-dependent
identities in iPSC-derived NPCs, we identified a significantly
smaller number of genes that were exclusively expressed at
similar levels in fNSCs and mesodermal NPCs (LOC339535 in
CD34-iPSC-NPCs and ZP3, POMZP3, VAV3 and VGF3 in Fib-
iPSC-NPCs) and for which, except for VGF3, neural functions
have not been described.
To further characterize reprogramming epigenetic memory in
neuroectoderm- and mesoderm-derived NPCs, we performed
whole-genome promoter methylation analysis on fNSC-iPSC-
NPCs, fNSCs, fNSC-iPSCs and CD34-iPSC-NPCs, CD34-
HSCs, and CD34-iPSCs using Nimble Gene promoter CpG
arrays (Figure S1E). iPSC-derived NPCs formed a distinct group
among all cell populations and clearly separated from their
iPSCs and their corresponding starting cells (CD34+ HSCs,
fNSCs). This finding indicates a significant change of epigenetic
marks throughout neural differentiation in both neuroectoderm-
and mesoderm-derived NPCs. Interestingly, however, we found
shorter distances between fNSC-iPSC-NPCs and fNSCs/fNSC-
iPSCs than between CD34-iPSC-NPCs and CD34-HSCs/CD34-
iPSCs, indicating smaller extent of epigenetic remodeling and
thus a higher number of conserved origin-specific methylation
marks in neuroectoderm-derived versus mesoderm-derived
NPCs (Figure S1E). In contrast to our transcriptomics data and
in contrast to previous methylation studies demonstrating
grouping of pluripotent stem cells and separation of these cells
from their starting cells (Bock et al., 2011; Lister et al., 2011),
fNSCs and fNSC-iPSCs clustered closest to each other, while
undifferentiated iPSCs did not cluster with undifferentiated
ESCs (Figure S1E). This could be due to the fact that our methyl-
ation analysis focused on gene promoter regions, while other
groups performed whole genome CpG methylation studies
covering both promoter and nonpromoter regions (Bock et al.,
2011; Lister et al., 2011; Nazor et al., 2012; Figure S1E). Further-
more, we have recently observed that the reprogramming mem-
ory effect can be much stronger at DNAmethylation level than at
transcriptomics level and have identified DNA sequence methyl-(L–Q) In an independent experiment, GFP+ fNSC-iPSC-NPCs and dtTomato+ Fib
from brains 10 weeks after transplantation by FACS.
(M) Quantification of isolated fluorescent cells.
(N) Scatterplot comparing gene expression between GFP+ and dtTomato+ cells.
(O) Heatmap representing global gene expression.
(P and Q) Hierarchical cluster analysis of (P) brain-associated neural genes and
Data are presented as mean + SEM. Unpaired t test was used as statistical test
Cell Reation patterns specific of reprogramming memory (Luu et al.,
2013). We next examined methylation profiles in promoter
regions of aforementioned memory genes in neuroectoderm-
and mesoderm-derived NPCs to determine whether transcrip-
tion profiles correlated with distinct epigenetic modifications
(Figure S1F). While 12 out of the 20 genetic loci were represented
on our Nimble Gene promoter CpG arrays, only 3 out of these 12
genes (NXPH1, MAL, and FAM150B) showed promoter methyl-
ation profiles, which correlated with the level of gene expression
in iPSC-derived NPCs (Figure S1F). These findings indicated that
epigenetic modifications besides promoter DNA methylation,
such as histone modifications, may be responsible for the regu-
lation of memory gene expression in iPSC-derived NPCs.
Origin-Dependent Neural Cell Identities Are Retained
after Transplantation of Neural Progenitor Cells into the
Adult Rodent Brain
So far, these results demonstrated distinct neural characteristics
in neuroectoderm- versus mesoderm-derived NPCs and elicited
the question if the somatic cell of origin influenced terminal neu-
ral differentiation of NPCs into mature neurons and astrocytes.
Thus, we first applied differentiation protocols to fNSC-iPSC-
NPCs, CD34-iPSC-NPCs, and Fib-iPSC-NPCs and quantified
immunostainings for bIII-tubulin, tyrosine hydroxylase (TH), and
glial fibrillary acidic protein (GFAP) as well as neurite formation
up to 5 weeks after in vitro differentiation (Figures 1H and 1I).
This analysis revealed similar neuronal and glial differentiation
and maturation capabilities between all NPC groups (Figure 1I).
However, this approach did not allow us to analyze whether
any neural context-dependent mechanisms influenced neural
identities during terminal differentiation of NPCs. Thus, as a
proof-of-principle experiment, we decided to transplant neuro-
ectoderm- and mesoderm-derived NPCs into the cortex and
striatum of adult mice, which comprise fNSC-derived telence-
phalic domains within the central nervous system. To visualize
cells in vivo, fNSC-iPSC-NPCs and Fib-iPSC-NPCs were labeled
with lentiviruses expressing either GFP or dtTomato red fluores-
cent protein (RFP) prior to transplantation (Figure 2A). We
transplanted cells as mixed cell populations consisting of 50%
fNSC-iPSC-NPCs and 50%Fib-iPSC-NPCs into the brain, which
enabled direct side-by-side analysis of cellular maturation and
survival in vivo. In parallel, nontransplanted mixed cell popula-
tions were replated in vitro demonstrating equal ratios of GFP+
and dtTomato+ NPCs (Figure 2B) as well as equivalent numbers
of proliferating (Figure 2C) and apoptotic profiles (Figure 2D). All
mice contained surviving grafts, which were stained for NeuN
and synaptophysin 10 weeks after transplantation (Figures 2E–
2K; Figure S2A). In line with our in vitro observations, neuronal
differentiation of GFP+ fNSC-iPSC-NPCs and dtTomato+ Fib-
iPSC-NPCswas similar within grafts, indicating cell-autonomous-iPSC-NPCs were transplanted into the cortex (n = 6) and cells were isolated
of (Q) memory signature genes in in vitro-cultured and transplanted cells.
(**p < 0.01; ***p < 0.001).
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maturation of neuroectoderm- and mesoderm-derived NPCs
in vivo (Figures 2G, 2H, 2J, and 2K; Figure S2A). Interestingly,
however, we discovered significantly increased numbers of
fNSC-iPSC-NPC-derived neural cells within mixed cortical and
also mixed striatal grafts (Figure 2F). These findings demon-
strated origin-dependent differences in survival of iPSC-derived
neurons in the brain and suggested that the neural niche pro-
vided a more favorable environment for neuroectodermal versus
mesodermal iPSC-derived neurons.
To further analyze if the neural niche and the origin of im-
planted cells influenced neural identities in vivo, we injected
GFP+ fNSC-iPSC-NPCs and dtTomato+ Fib-iPSC-NPCs in an in-
dependent experiment as pure populations into the left and right
cortex of adult mice and isolated fluorescent cells from the brain
by fluorescence-activated cell sorting (FACS) 10 weeks after
transplantation (Figures 2L–2Q). Whole-genome gene expres-
sion analysis on isolated cells revealed a separation of the trans-
planted groups from in vitro-cultured NPCs, reflecting further
maturation of progenitor cells into neurons in vivo (Figure 2O;
Figure S2B). Concordant with the in vitro data, transplanted
NPCs formed a separate cluster when examining expression
profiles of brain-associated neural genes, and within the in vivo-
group, neuroectoderm-derived neurons clearly separated from
mesoderm-derived cells (Figure 2P; Figure S2C). Notably,
expression of aforementioned neural signature genes was re-
tained in transplanted fNSC-iPSC-NPCs, which clustered with
neuroectoderm-derived fNSCs and cultured fNSC-iPSC-NPCs,
while implanted Fib-iPSC-NPCs formed a separate cluster with
all mesoderm-derived neural cells (Figure 2Q; Figure S2D).
Our findings demonstrate distinct origin-dependent neural cell
identities in human iPSC-derived NPCs in vitro and after trans-
plantation into the adult rodent brain. Interestingly, these differ-
ences occurred, although we had used a differentiation protocol,
which applies strong guidance cues to undifferentiated iPSCs to
efficiently generate homogenous neural cell populations with
distinct caudal positional identities (Reinhardt et al., 2013a). It
should be noted, though, that both neuroectoderm- and meso-
derm-derived NPCs showed robust and comparable differentia-
tion into neurons in vitro and in vivo. We do not argue to use
NSCs as starting populations to derive iPSCs (Kim et al., 2009)
when intending neurodegenerative diseasemodeling due to their
lack of availability. In fact, we have recently demonstrated that
Parkinson’s disease patient-derived Fib-iPSC-NPCs, differenti-
ated according to our protocol, comprise suitable cell sources
for such purposes (Reinhardt et al., 2013a). However, we would
like to raise the point that origin-dependent neural cell identities
can exist in human iPSC-derived NPCs.EXPERIMENTAL PROCEDURES
Derivation and Culture of Neural Progenitor Cells
NPCs were generated and cultured as previously described (Reinhardt et al.,
2013a). Briefly, higher-passage pluripotent stem cell colonies (see Supple-
mental Experimental Procedures for further information) were detached from
mouse embryonic fibroblasts 3–4 days after splitting using 2 mg/ml collage-
nase IV. Pieces of colonies were collected by sedimentation and resuspended
in human ESC medium (without FGF2) supplemented with 10 mM SB-431542
(Ascent Scientific), 1 mM dorsomorphin (Tocris), 3 mM CHIR 99021 (Axon
Medchem), and 0.5 mM purmorphamine (PMA; Alexis) and subsequently1702 Cell Reports 8, 1697–1703, September 25, 2014 ª2014 The Aucultured as embryoid bodies (EBs) in Petri dishes. On day 2, medium was
changed to N2B27medium containing the same small-molecule supplements.
N2B27 medium consisted of Dulbecco’s modified Eagle’s medium (DMEM)-
F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement
(Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with 1%peni-
cillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin
were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the
medium. On day 6, EBs were triturated into smaller pieces and plated on
Matrigel-coated (Matrigel, growth factor reduced, high concentration; BD
Biosciences) 12-well plates (Nunc) in NPC expansion medium (N2B27 with
CHIR, PMA, and AA). Medium was changed every other day and cells were
typically split 1:10–1:15 every 5–6 days. For splitting, cells were digested to
single cells for approximately 10 min at 37C using prewarmed Accutase
(PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for
5 min. The cell pellet was resuspended in fresh NPC expansion medium and
plated on Matrigel-coated cell culture dishes.
Transplantation
GFP-labeled fNSC-iPSC-NPCs or tdTomato-labeled Fib-iPSC-NPCs were
trypsinized and resuspended to single cells in DMEM-F12 (Invitrogen) at a den-
sity of 50,000 cells per ml. Threemicroliters of the cell suspension were injected
into the right (n = 8) and left (n = 8) hemisphere of the adult mice (n = 8;
NOD.CB17-Prkdcscid/NCrHsd mice; Harlan Laboratories) by using a Hamil-
ton 7005KH 5 ml syringe. For intracortical and intrastriatal transplantation of
mixed cell populations, cell suspensions were mixed in a ratio of 1:1 prior to
transplantation. Independent cell preparations were performed for each
mouse. Please see Supplemental Experimental Procedures for more details.
All cell transplantation experiments were carried out in accordance with local
institutional guidelines under the protocol 87- 51.04.2011.A057, which was
approved by Landesamt fu¨r Natur, Umwelt und Verbraucherschutz of the state
of North Rhine-Westphalia, Germany.
Whole-Genome Expression Analysis
RNA samples for microarray analysis were prepared using RNeasy columns
(QIAGEN) with on-column DNA digestion. 300 ng of total RNA per sample
was used as the input in the linear amplification protocol (Ambion), which
involved the synthesis of T7-linked double-stranded cDNA and 12 hr of
in vitro transcription incorporating biotin-labeled nucleotides. Purified and
labeled cDNA was then hybridized for 18 hr onto HumanHT-12 v4 expression
BeadChips (Illumina) following the manufacturer’s instructions. After the rec-
ommended washing, the chips were stained with streptavidin-Cy3 (GEHealth-
care) and scanned using the iScan reader (Illumina) and the accompanying
software. The samples were exclusively hybridized as biological replicates.
The RNA samples from in vivo transplanted and FACS-sorted cells were
amplified using the TargetAmp 2-Round Biotin-aRNA Amplification Kit 3.0
(Epicenter) from 100 pg to 50 mg.
The bead intensities were mapped to gene information using BeadStudio
3.2 (Illumina), and background correction was performed using the Affymetrix
robust multiarray analysis (RMA) background correction model (Irizarry et al.,
2003). Variance stabilization was performed using the log2 scaling, and gene
expression normalization was calculated with the quantile method imple-
mented in the lumi package of R-Bioconductor. Data postprocessing and
graphics were performed with in-house-developed functions in MATLAB
(MathWorks). Hierarchical clusters of genes and samples were identified
with the one minus the sample correlation metric and the unweighted pair-
group method using average (UPGMA) linkage method as previously
described (Kim et al., 2009). To identify genes associated with retained
reprogramming memory after iPSC differentiation, averages of replicates of
respective transcriptomics profiles were calculated before determining differ-
entially expressed genes (DEGs) in iPSC-derived NPCs (Fib-4FiPSCa-NPCs,
Fib-4FiPSCb-NPCs, and Fib-4FiPSCc-NPCs; CD34-2FiPSCa-NPCs, CD34-
4FiPSCa-NPCs, and CD34-4FiPSCb-NPCs; fNSCs-1FiPSCa-NPCs, fNSCs-
1FiPSCb-NPCs, and fNSCs-2FiPSCa-NPCs) in relation to fNSCs using a
fold-change threshold of the absolute value of the replicate mean differences
of 4 (for each pairwise comparison) and selecting for those genes that
were specific, common DEGs in respective intersections (three intersections
of DEGs of fNSC-iPSC-NPCs versus fNSCs, intersected with the threethors
intersections of DEGs of Fib-iPSC-NPCs versus fNSCs, intersected with the
three intersections of DEGs of CD34-iPSC-NPCs versus fNSCs). The list of
brain-associated neural genes was retrieved from the TiGER database at
Wilmer Eye Institute of Johns Hopkins University (Liu et al., 2008).
ACCESSION NUMBERS
The data discussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus (GEO) and are accessible through GEO Series
accession number GSE55107 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE55107).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.08.014.
AUTHOR CONTRIBUTIONS
G.H., M.E., J.S., H.R.S., T.K., and H.Z. developed and designed the study;
G.H., M.E., K.H., A.L.H., P.R., K.P.K., K.A., M.F., and C.O. performed experi-
ments; G.H., M.E., M.J.A.B., K.H., A.L.H., J.C.S., A.S., J.S., T.K., and H.Z.
analyzed data; M.J.A.B. performed bioinformatics analysis; K.H. performed
in vivo transplantations; J.B.K., S.S., and F.G. contributed reagents/mate-
rials/analysis tools; and G.H., M.E., H.R.S., T.K., and H.Z. wrote the manu-
script. M.J.A.B. and K.H. have contributed equally.
ACKNOWLEDGMENTS
We would like to thank Martina Radstaak, Ingrid Gelker, Elke Hoffmann, Clau-
dia Ortmeier, and Martina Sinn for outstanding technical assistance; Martin
Stehling for excellent FACS analysis; and Axel Schambach and Christopher
Baum,MHH (Hannover, Germany), for providing the lentiviral SFFV reprogram-
ming vectors. This study was supported by research funding from the IMF at
University Hospital Mu¨nster (I-HA-111219) to G.H., from a Pe´lican award
from the Fondation du Pe´lican de Mie et Pierre Hippert-Faber to K.H., by a
grant from the National Research Foundation of Korea (NRF) (2010-
0020277, 2012M3A9C6049790, 2010-0028684) to J.B.K., from the German
Research Foundation (DFG; Emmy Noether Program, SCHW1392/2-1;
SFB629 and SPP1356, SCHW1392/4-1), the Schram-Stiftung (T287/21795/
2011) and the Fonds National de la Recherche Luxembourg (to J.C.S.), the
German Research Foundation (DFG: SFB-TRR128-B7, to T.K.), and the
German Federal Ministry of Education and Research (grants BMBF
01GN1008B and BMBF 01GN1006D, to H.R.S. and H.Z.).
Received: January 29, 2014
Revised: May 26, 2014
Accepted: August 7, 2014
Published: September 11, 2014
REFERENCES
Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z.D., Ziller,
M., Croft, G.F., Amoroso, M.W., Oakley, D.H., et al. (2011). Reference Maps of
human ES and iPS cell variation enable high-throughput characterization of
pluripotent cell lines. Cell 144, 439–452.
Borst, J., Hendriks, J., and Xiao, Y. (2005). CD27 and CD70 in T cell and B cell
activation. Curr. Opin. Immunol. 17, 275–281.
Han, J., Jung, S., Jang, J., Kam, T.I., Choi, H., Kim, B.J., Nah, J., Jo, D.G.,
Nakagawa, T., Nishimura, M., et al. (2014). OCIAD2 activates gamma-secre-
tase to enhance amyloid beta production by interacting with nicastrin. Cell.
Mol. Life Sci. 71, 2561–2576.
Hargus, G., Ehrlich, M., Hallmann, A.L., and Kuhlmann, T. (2014). Human stem
cell models of neurodegeneration: a novel approach to study mechanisms of
disease development. Acta Neuropathol. 127, 151–173.Cell ReIrizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B., and Speed, T.P.
(2003). Summaries of Affymetrix GeneChip probe level data. Nucleic Acids
Res. 31, e15.
Kim, H.T., Kim, I.S., Lee, I.S., Lee, J.P., Snyder, E.Y., and Park, K.I. (2006). Hu-
man neurospheres derived from the fetal central nervous system are regionally
and temporally specified but are not committed. Exp. Neurol. 199, 222–235.
Kim, J.B., Greber, B., Arau´zo-Bravo, M.J., Meyer, J., Park, K.I., Zaehres, H.,
and Scho¨ler, H.R. (2009). Direct reprogramming of human neural stem cells
by OCT4. Nature 461, 649–653.
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji,
H., Ehrlich, L.I., et al. (2010). Epigenetic memory in induced pluripotent stem
cells. Nature 467, 285–290.
Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., Huo, H., Loh,
Y.H., Aryee, M.J., Lensch, M.W., et al. (2011). Donor cell type can influence
the epigenome and differentiation potential of human induced pluripotent
stem cells. Nat. Biotechnol. 29, 1117–1119.
Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosie-
wicz-Bourget, J., O’Malley, R., Castanon, R., Klugman, S., et al. (2011). Hot-
spots of aberrant epigenomic reprogramming in human induced pluripotent
stem cells. Nature 471, 68–73.
Liu, X., Yu, X., Zack, D.J., Zhu, H., and Qian, J. (2008). TiGER: a database for
tissue-specific gene expression and regulation. BMC Bioinformatics 9, 271.
Luu, P.L., Scho¨ler, H.R., and Arau´zo-Bravo, M.J. (2013). Disclosing the cross-
talk among DNA methylation, transcription factors, and histone marks in hu-
man pluripotent cells through discovery of DNA methylation motifs. Genome
Res. 23, 2013–2029.
Mekhoubad, S., Bock, C., de Boer, A.S., Kiskinis, E., Meissner, A., and Eggan,
K. (2012). Erosion of dosage compensation impacts human iPSC disease
modeling. Cell Stem Cell 10, 595–609.
Nazor, K.L., Altun, G., Lynch, C., Tran, H., Harness, J.V., Slavin, I., Garitaonan-
dia, I., Mu¨ller, F.J., Wang, Y.C., Boscolo, F.S., et al. (2012). Recurrent varia-
tions in DNA methylation in human pluripotent stem cells and their
differentiated derivatives. Cell Stem Cell 10, 620–634.
Petrenko, A.G., Ullrich, B., Missler, M., Krasnoperov, V., Rosahl, T.W., and
Su¨dhof, T.C. (1996). Structure and evolution of neurexophilin. J. Neurosci.
16, 4360–4369.
Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Aposto-
lou, E., Stadtfeld, M., Li, Y., Shioda, T., et al. (2010). Cell type of origin influ-
ences the molecular and functional properties of mouse induced pluripotent
stem cells. Nat. Biotechnol. 28, 848–855.
Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C.S., Ho¨ing, S.,
Moritz, S., Parga, J.A., Wagner, L., Bruder, J.M., et al. (2013a). Derivation
and expansion using only small molecules of human neural progenitors for
neurodegenerative disease modeling. PLoS ONE 8, e59252.
Reinhardt, P., Schmid, B., Burbulla, L.F., Scho¨ndorf, D.C., Wagner, L., Glatza,
M., Ho¨ing, S., Hargus, G., Heck, S.A., Dhingra, A., et al. (2013b). Genetic
correction of a LRRK2 mutation in human iPSCs links parkinsonian neurode-
generation to ERK-dependent changes in gene expression. Cell Stem Cell
12, 354–367.
Sloan, J.L., Johnston, J.J., Manoli, I., Chandler, R.J., Krause, C., Carrillo-Car-
rasco, N., Chandrasekaran, S.D., Sysol, J.R., O’Brien, K., Hauser, N.S., et al.;
NIH Intramural Sequencing Center Group (2011). Exome sequencing identifies
ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nat.
Genet. 43, 883–886.
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Har-
gus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009). Parkinson’s disease
patient-derived induced pluripotent stem cells free of viral reprogramming fac-
tors. Cell 136, 964–977.
Stahl, R., Walcher, T., De Juan Romero, C., Pilz, G.A., Cappello, S., Irmler, M.,
Sanz-Aquela, J.M., Beckers, J., Blum, R., Borrell, V., and Go¨tz, M. (2013).
Trnp1 regulates expansion and folding of the mammalian cerebral cortex by
control of radial glial fate. Cell 153, 535–549.ports 8, 1697–1703, September 25, 2014 ª2014 The Authors 1703
